Selective continuous elimination of low density lipoproteins (LDL) by heparin precipitation: first clinical application.
D000328:Adult; D000990:Antithrombin III / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D011232:Chemical Precipitation; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000628:therapy*; D008077:Lipoproteins, LDL / Q000097:blood* / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D010953:Plasma Volume; D010958:Plasminogen / Q000032:analysis
D001798:Blood Proteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008077:Lipoproteins, LDL; D000990:Antithrombin III; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin